👉 RYMV stands for Recombinant Human Monoclonal Antibody Variant, which is a type of monoclonal antibody used in immunotherapy. It was developed by researchers at the University of California, San Francisco (UCSF) to treat various types of cancer. This antibody variant has been shown to be effective in treating multiple types of leukemia and lymphoma, with improved efficacy compared to traditional monoclonal antibodies.
